Published in Diabetes on March 01, 2005
The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) study. Contemp Clin Trials (2006) 1.05
Differential effects of calorie restriction and exercise on the adipose transcriptome in diet-induced obese mice. J Obes (2011) 0.88
The effect of the holiday season on body weight and composition in college students. Nutr Metab (Lond) (2006) 0.88
CB1 blockade potentiates down-regulation of lipogenic gene expression in perirenal adipose tissue in high carbohydrate diet-induced obesity. PLoS One (2014) 0.85
The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a cross-sectional study. Nutr J (2013) 0.77
Influence of Physical Activity Participation on the Associations between Eating Behaviour Traits and Body Mass Index in Healthy Postmenopausal Women. J Obes (2010) 0.77
Discordances among different tools used to estimate cardiovascular risk in postmenopausal women. Can J Cardiol (2009) 0.76
Endogenous Sex Steroid Hormones, Lipid Subfractions, and Ectopic Adiposity in Asian Indians. Metab Syndr Relat Disord (2015) 0.75
The human obesity gene map: the 2005 update. Obesity (Silver Spring) (2006) 7.17
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med (2015) 5.59
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol (2008) 5.19
Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care (2005) 1.96
Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ (2005) 1.86
Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension (2005) 1.83
Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol (2007) 1.64
The human obesity gene map: the 2004 update. Obes Res (2005) 1.64
Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr (2008) 1.57
Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins. Am J Clin Nutr (2002) 1.49
Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Nutr J (2004) 1.45
Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes. Clin Endocrinol (Oxf) (2011) 1.42
Effects of intense and prolonged exercise on insulin sensitivity and glycogen metabolism in hypertensive subjects. Circulation (2003) 1.42
Eating behaviors and indexes of body composition in men and women from the Québec family study. Obes Res (2003) 1.41
Physical training reverses defect in 3-ketoacid CoA-transferase activity in skeletal muscle of diabetic rats. Am J Physiol Endocrinol Metab (2005) 1.40
Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab (2008) 1.39
Exercise-induced hypertension in men with metabolic syndrome: anthropometric, metabolic, and hemodynamic features. Metab Syndr Relat Disord (2012) 1.39
Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol (2005) 1.38
Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab (2005) 1.37
The human obesity gene map: the 2003 update. Obes Res (2004) 1.36
Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab (2004) 1.36
Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem (2004) 1.33
The human obesity gene map: the 2001 update. Obes Res (2002) 1.32
What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care (2004) 1.29
Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) (2006) 1.25
Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol (2008) 1.25
Effect of a nutritional intervention promoting the Mediterranean food pattern on plasma lipids, lipoproteins and body weight in healthy French-Canadian women. Atherosclerosis (2003) 1.20
Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr (2002) 1.16
Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity (Silver Spring) (2012) 1.14
Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference. Can J Cardiol (2011) 1.12
Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol (2002) 1.11
Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women. Metabolism (2011) 1.10
Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr (2006) 1.10
Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study. Atherosclerosis (2005) 1.09
The human obesity gene map: the 2002 update. Obes Res (2003) 1.08
Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. Clin Biochem (2003) 1.05
Dietary cod protein improves insulin sensitivity in insulin-resistant men and women: a randomized controlled trial. Diabetes Care (2007) 1.05
Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J Lipid Res (2007) 1.04
Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism (2009) 1.04
Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet (2004) 1.03
Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. Am J Clin Nutr (2003) 1.03
Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation. Nutrients (2012) 1.02
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update. Can J Cardiol (2013) 1.01
Neuromedin beta: a strong candidate gene linking eating behaviors and susceptibility to obesity. Am J Clin Nutr (2004) 1.01
Transcriptomic and metabolomic signatures of an n-3 polyunsaturated fatty acids supplementation in a normolipidemic/normocholesterolemic Caucasian population. J Nutr Biochem (2012) 1.00
Psychobiological impact of a progressive weight loss program in obese men. Physiol Behav (2005) 1.00
Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French-Canadians. J Mol Med (Berl) (2006) 1.00
Effects of dietary factors on oxidation of low-density lipoprotein particles. J Nutr Biochem (2006) 1.00
Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity. Thorax (2012) 1.00
Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Metabolism (2003) 0.99
Sex differences in the impact of the Mediterranean diet on cardiovascular risk profile. Br J Nutr (2012) 0.99
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo. Lipids Health Dis (2004) 0.99
Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr (2007) 0.99
Prevention of gestational diabetes mellitus: a review of studies on weight management. Diabetes Metab Res Rev (2010) 0.99
Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. Am J Physiol Heart Circ Physiol (2008) 0.98
Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metabolism (2003) 0.98
Weight gain measures in women with gestational diabetes mellitus. J Womens Health (Larchmt) (2011) 0.98
Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women. Atherosclerosis (2006) 0.98
Familial resemblance in eating behaviors in men and women from the Quebec Family Study. Obes Res (2005) 0.97
Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr (2005) 0.96
Familial aggregation of blood lipid response to exercise training in the health, risk factors, exercise training, and genetics (HERITAGE) Family Study. Circulation (2002) 0.95
Leptin and leptin receptor gene polymorphisms and changes in glucose homeostasis in response to regular exercise in nondiabetic individuals: the HERITAGE family study. Diabetes (2004) 0.95
Eating behaviours, dietary profile and body composition according to dieting history in men and women of the Québec Family Study. Br J Nutr (2004) 0.95
Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men. Metabolism (2012) 0.94
Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. J Nutrigenet Nutrigenomics (2013) 0.94
HDL particle size: a marker of the gender difference in the metabolic risk profile. Atherosclerosis (2002) 0.94
The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet (2003) 0.94
Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). Am J Cardiol (2002) 0.94
Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels. J Lipid Res (2009) 0.94
Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance. Diabetes Care (2003) 0.93
Associations between dietary patterns and gene expression profiles of healthy men and women: a cross-sectional study. Nutr J (2013) 0.93
Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men. Br J Nutr (2009) 0.92
Health-At-Every-Size and eating behaviors: 1-year follow-up results of a size acceptance intervention. J Am Diet Assoc (2009) 0.92
Waist girth does not predict metabolic complications in severely obese men. Diabetes Care (2006) 0.92
Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism (2004) 0.92
Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity. Metabolism (2011) 0.92
Regional body fat distribution and metabolic profile in postmenopausal women. Metabolism (2008) 0.92
Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women. Diabetes Care (2007) 0.92
Visceral adiposity and endothelial lipase. J Clin Endocrinol Metab (2006) 0.91
Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus. Metabolism (2008) 0.91
Safety and magnitude of changes in blood glucose levels following exercise performed in the fasted and the postprandial state in men with type 2 diabetes. Eur J Cardiovasc Prev Rehabil (2007) 0.90